{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:43:18Z","timestamp":1786293798929,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,9]]},"DOI":"10.7759\/cureus.114211","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:27:14Z","timestamp":1786292834000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Serotonin Syndrome With Acute Respiratory Failure Following Ayahuasca and Dextromethorphan Use: A Case Report"],"prefix":"10.7759","author":[{"given":"Sean","family":"Pack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler  R","family":"Ellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer EW","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005, 352:1112-20. 10.1056\/NEJMra041867","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Prevention, recognition, and management of serotonin syndrome","volume":"81","author":"Ables AZ","year":"2010","unstructured":"Ables AZ, Nagubilli R. Prevention, recognition, and management of serotonin syndrome. Am Fam Physician. 2010, 81:1139-42.","journal-title":"Am Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05876-x","article-title":"Serotonin toxicity of serotonergic psychedelics","volume":"239","author":"Malcolm B","year":"2022","unstructured":"Malcolm B, Thomas K. Serotonin toxicity of serotonergic psychedelics. Psychopharmacology (Berl). 2022, 239:1881-91. 10.1007\/s00213-021-05876-x","journal-title":"Psychopharmacology (Berl)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ph13110334","article-title":"Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact","volume":"13","author":"Brito-da-Costa AM","year":"2020","unstructured":"Brito-da-Costa AM, Dias-da-Silva D, Gomes NG, Dinis-Oliveira RJ, Madureira-Carvalho \u00c1. Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact. Pharmaceuticals (Basel). 2020, 13:334. 10.3390\/ph13110334","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff CM","year":"2020","unstructured":"Reiff CM, Richman EE, Nemeroff CB, et al.. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry. 2020, 177:391-410. 10.1176\/appi.ajp.2019.19010035","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05353-6","article-title":"Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors","volume":"81","author":"Egger K","year":"2024","unstructured":"Egger K, Aicher HD, Cumming P, Scheidegger M. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors. Cell Mol Life Sci. 2024, 81:395. 10.1007\/s00018-024-05353-6","journal-title":"Cell Mol Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0378-8741(84)90003-5","article-title":"Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca","volume":"10","author":"McKenna DJ","year":"1984","unstructured":"McKenna DJ, Towers GH, Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol. 1984, 10:195-223. 10.1016\/0378-8741(84)90003-5","journal-title":"J Ethnopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/10915818241230916","article-title":"Ayahuasca and dimethyltryptamine adverse events and toxicity analysis: a systematic thematic review","volume":"43","author":"White E","year":"2024","unstructured":"White E, Kennedy T, Ruffell S, Perkins D, Sarris J. Ayahuasca and dimethyltryptamine adverse events and toxicity analysis: a systematic thematic review. Int J Toxicol. 2024, 43:327-39. 10.1177\/10915818241230916","journal-title":"Int J Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701606443","article-title":"Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Chyka PA","year":"2007","unstructured":"Chyka PA, Erdman AR, Manoguerra AS, et al.. Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007, 45:662-77. 10.1080\/15563650701606443","journal-title":"Clin Toxicol (Phila)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.45.2.219","article-title":"Serotonin syndrome","volume":"45","author":"Bodner RA","year":"1995","unstructured":"Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology. 1995, 45:219-23. 10.1212\/wnl.45.2.219","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01691.x","article-title":"The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper","volume":"50","author":"Evans RW","year":"2010","unstructured":"Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache. 2010, 50:1089-99. 10.1111\/j.1526-4610.2010.01691.x","journal-title":"Headache"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2163","article-title":"Implications of off-target serotoninergic drug activity: an analysis of serotonin syndrome reports using a systematic bioinformatics approach","volume":"38","author":"Culbertson VL","year":"2018","unstructured":"Culbertson VL, Rahman SE, Bosen GC, Caylor ML, Echevarria MM, Xu D. Implications of off-target serotoninergic drug activity: an analysis of serotonin syndrome reports using a systematic bioinformatics approach. Pharmacotherapy. 2018, 38:888-98. 10.1002\/phar.2163","journal-title":"Pharmacotherapy"},{"key":"ref13","unstructured":"U.S. Food and Drug Administration. Diphenhydramine hydrochloride drug label. (2024). Accessed. May 21, 2026: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.886408","article-title":"Monoamine oxidase inhibition by plant-derived \u03b2-carbolines; implications for the psychopharmacology of tobacco and ayahuasca","volume":"13","author":"Berlowitz I","year":"2022","unstructured":"Berlowitz I, Egger K, Cumming P. Monoamine oxidase inhibition by plant-derived \u03b2-carbolines; implications for the psychopharmacology of tobacco and ayahuasca. Front Pharmacol. 2022, 13:886408. 10.3389\/fphar.2022.886408","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley EJ","year":"2003","unstructured":"Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003, 96:635-42. 10.1093\/qjmed\/hcg109","journal-title":"QJM"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach H","year":"1991","unstructured":"Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991, 148:705-13. 10.1176\/ajp.148.6.705","journal-title":"Am J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31825ae0f8","article-title":"Treatment of four psychiatric emergencies in the intensive care unit","volume":"40","author":"Bienvenu OJ","year":"2012","unstructured":"Bienvenu OJ, Neufeld KJ, Needham DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med. 2012, 40:2662-70. 10.1097\/CCM.0b013e31825ae0f8","journal-title":"Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12796","article-title":"An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System","volume":"44","author":"Nguyen H","year":"2019","unstructured":"Nguyen H, Pan A, Smollin C, Cantrell LF, Kearney T. An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System. J Clin Pharm Ther. 2019, 44:327-34. 10.1111\/jcpt.12796","journal-title":"J Clin Pharm Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/1742-6723.14554","article-title":"Review article: efficacy of cyproheptadine in the management of serotonin toxicity following deliberate self-poisoning - a systematic review","volume":"37","author":"King E","year":"2025","unstructured":"King E, Rotella JA. Review article: efficacy of cyproheptadine in the management of serotonin toxicity following deliberate self-poisoning - a systematic review. Emerg Med Australas. 2025, 37:e14554. 10.1111\/1742-6723.14554","journal-title":"Emerg Med Australas"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-025-01256-7","article-title":"Safety and efficacy of monoamine oxidase inhibitors in patients who use psychoactive substances: potential drug interactions and substance use disorder treatment data","volume":"40","author":"Rached G","year":"2026","unstructured":"Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS. Safety and efficacy of monoamine oxidase inhibitors in patients who use psychoactive substances: potential drug interactions and substance use disorder treatment data. CNS Drugs. 2026, 40:359-417. 10.1007\/s40263-025-01256-7","journal-title":"CNS Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/500155-severe-serotonin-syndrome-with-acute-respiratory-failure-following-ayahuasca-and-dextromethorphan-use-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:27:15Z","timestamp":1786292835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/500155-severe-serotonin-syndrome-with-acute-respiratory-failure-following-ayahuasca-and-dextromethorphan-use-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.114211","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}